West Oak Capital, LLC Amgen Inc Transaction History

West Oak Capital, LLC

  • $5.38 Billion
  • Q3 2024

A detailed history of West Oak Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, West Oak Capital, LLC holds 8,823 shares of AMGN stock, worth $2.29 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
8,823
Previous 8,953 1.45%
Holding current value
$2.29 Million
Previous $2.8 Million 916.41%
% of portfolio
0.53%
Previous 1.56%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
SELL
$309.38 - $337.38 $40,219 - $43,859
-130 Reduced 1.45%
8,823 $28.4 Million
Q2 2024

Jul 24, 2024
BUY
$262.75 - $319.31 $109,566 - $133,152
417 Added 4.89%
8,953 $2.8 Million
Q1 2024

Apr 18, 2024
BUY
$268.87 - $324.56 $15,863 - $19,149
59 Added 0.7%
8,536 $2.43 Million
Q4 2023

Jan 17, 2024
SELL
$255.7 - $288.46 $65,203 - $73,557
-255 Reduced 2.92%
8,477 $2.6 Million
Q3 2023

Oct 05, 2023
BUY
$218.65 - $271.46 $68,218 - $84,695
312 Added 3.71%
8,732 $2.35 Million
Q2 2023

Jul 19, 2023
SELL
$214.27 - $253.37 $118,919 - $140,620
-555 Reduced 6.18%
8,420 $1.87 Million
Q1 2023

Apr 21, 2023
BUY
$225.79 - $275.2 $66,608 - $81,184
295 Added 3.4%
8,975 $2.17 Million
Q4 2022

Jan 05, 2023
SELL
$229.03 - $291.01 $88,176 - $112,038
-385 Reduced 4.25%
8,680 $2.28 Million
Q3 2022

Oct 28, 2022
SELL
$224.46 - $253.15 $8,978 - $10,126
-40 Reduced 0.44%
9,065 $2.04 Million
Q2 2022

Jul 11, 2022
SELL
$230.71 - $256.74 $56,985 - $63,414
-247 Reduced 2.64%
9,105 $2.22 Million
Q1 2022

Apr 20, 2022
BUY
$219.27 - $242.57 $6,578 - $7,277
30 Added 0.32%
9,352 $2.26 Million
Q4 2021

Jan 12, 2022
SELL
$198.88 - $227.6 $18,893 - $21,622
-95 Reduced 1.01%
9,322 $2.1 Million
Q3 2021

Oct 07, 2021
BUY
$212.27 - $248.7 $38,845 - $45,512
183 Added 1.98%
9,417 $2 Million
Q2 2021

Jul 20, 2021
BUY
$233.58 - $259.14 $43,212 - $47,940
185 Added 2.04%
9,234 $2.25 Million
Q1 2021

Apr 13, 2021
BUY
$221.91 - $258.6 $15,533 - $18,102
70 Added 0.78%
9,049 $2.25 Million
Q4 2020

Jan 08, 2021
BUY
$216.38 - $257.67 $86,552 - $103,068
400 Added 4.66%
8,979 $2.06 Million
Q3 2020

Oct 09, 2020
SELL
$234.65 - $260.95 $149,941 - $166,747
-639 Reduced 6.93%
8,579 $2.18 Million
Q2 2020

Jul 06, 2020
SELL
$197.81 - $242.74 $44,507 - $54,616
-225 Reduced 2.38%
9,218 $2.17 Million
Q1 2020

Apr 07, 2020
BUY
$182.24 - $241.7 $17,130 - $22,719
94 Added 1.01%
9,443 $1.91 Million
Q4 2019

Jan 09, 2020
SELL
$189.21 - $243.2 $197,346 - $253,657
-1,043 Reduced 10.04%
9,349 $2.25 Million
Q3 2019

Oct 02, 2019
SELL
$174.11 - $208.62 $73,996 - $88,663
-425 Reduced 3.93%
10,392 $2.01 Million
Q2 2019

Jul 12, 2019
BUY
$166.7 - $195.41 $128,358 - $150,465
770 Added 7.66%
10,817 $1.99 Million
Q1 2019

Apr 03, 2019
BUY
$180.87 - $203.88 $13,565 - $15,291
75 Added 0.75%
10,047 $1.91 Million
Q4 2018

Jan 08, 2019
SELL
$178.4 - $208.25 $1,427 - $1,666
-8 Reduced 0.08%
9,972 $1.94 Billion
Q3 2018

Oct 04, 2018
BUY
$185.29 - $208.89 $7,411 - $8,355
40 Added 0.4%
9,980 $2.07 Billion
Q2 2018

Jul 06, 2018
SELL
$166.05 - $186.51 $651,746 - $732,051
-3,925 Reduced 28.31%
9,940 $1.83 Billion
Q1 2018

Apr 05, 2018
BUY
$169.43 - $198.0 $679,753 - $794,376
4,012 Added 40.72%
13,865 $2.36 Billion
Q4 2017

Jan 05, 2018
SELL
$168.79 - $188.59 $28,694 - $32,060
-170 Reduced 1.7%
9,853 $1.71 Billion
Q3 2017

Oct 10, 2017
BUY
$167.29 - $191.0 $1.68 Million - $1.91 Million
10,023
10,023 $1.87 Billion

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $139B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track West Oak Capital, LLC Portfolio

Follow West Oak Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email